Ductal carcinoma in situ of the breast: A comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors

Breast Journal

Volumn 8, Issue 3, 2002, Pages 139-144

  Ruiz, Amparo ^a   Almenar, Sergio ^b   Cerdá, Miguel ^a   Hidalgo, Juan José ^a   Puchades, Alfonso ^c   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Valencian Institute of Oncology   (Spain)

^c UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Carcinoma in situ; DNA ploidy; Image analysis; Microvascular density; Nuclear area

Indexed keywords

CANCER GRADING; CAPILLARY DENSITY; CARCINOMA IN SITU; CELL NUCLEUS; CELL STRUCTURE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); PLOIDY;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL NUCLEUS; DNA, NEOPLASM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOVASCULARIZATION, PATHOLOGIC; PLOIDIES;

EID: 0036285854     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2002.08303.x     Document Type: Conference Paper

References (40)

1. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast
2. Extent, distribution and mammographic histological correlations of breast ductal carcinoma in situ
3. Radiology of in situ (intraductal) carcinoma of the breast: Study of radiopathologic correlation
4. Ductal carcinoma in situ: A proposal for a new classification
5. In situ carcinoma of the breast: Histologic types and proposed classification
6. Mammographically detected ductal carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
7. Pathologic findings from the National Surgical Adjuvant Breast Project (NASBP): Protocol B-17: Intraductal carcinoma (ductal carcinoma in situ)
8. Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breast
9. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast
10. What is the evidence that tumors are angiogenesis dependent?
11. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation
12. Angiogenic factors
13. Microvessel quantitation and prognosis in invasive breast carcinoma
14. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
15. Tumour microvessel density, p53 expression, tumour size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
16. Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma
17. Angiogenesis in ductal breast carcinoma: Comparison of microvessel density between primary tumour and lymph node metastasis
18. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
19. Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features
20. Angiogenesis as a marker of preneoplastic lesions of the human breast
21. Angiogenesis induced by "normal" human breast tissue: A probable marker for precancer
22. Comparative morphometric evaluation of microvessel density and nuclear area in ductal carcinoma in situ and hyperplastic ductal breast lesions
23. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications
24. Prognostic classification of breast ductal carcinoma-in-situ
25. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression
26. Benign, preinvasive and invasive ductal breast lesions: A comparative study with quantitative techniques: Morphometry, image- and flow cytometry
27. Ductal carcinoma in situ
28. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast
29. Quantitative study of ductal breast cancer progression: Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions
30. Characterization by image cytometry of duct epithelial proliferative disease of the breast
31. Quantitative study of ductal breast cancer. A progression index (PI) for premalignant lesions and in situ carcinoma
32. In situ carcinoma of the breast
33. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions
34. Ductal carcinoma in situ of the breast: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erB-2 protein
35. DNA ploidy in intraductal breast carcinomas
36. DNA analysis of ductal carcinoma in situ of the breast
37. Microvessel quantitation in intraductal and early invasive breast carcinoma
38. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of mode metastases and survival in breast cancer
39. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast